Topic

Cigna

A collection of 1335 issues

Renewing Raxone (Idebenone) Approval with Cigna in Virginia: Timeline, Documentation, and Coverage Lapse Solutions

Answer Box: Renewing Your Raxone (Idebenone) Approval Cigna requires annual prior authorization renewals for Raxone (idebenone) through Express Scripts/Accredo, typically 30-60 days before current approval expires. Submit renewal via CoverMyMeds, Evicore ePA, or MyAccredoPatients with updated clinical documentation proving ongoing LHON progression, visual response monitoring, and adherence. If coverage

Do You Qualify for Strensiq (asfotase alfa) Coverage by Cigna in Virginia? Decision Tree & Next Steps

Answer Box: Your Path to Strensiq Coverage in Virginia Yes, Cigna covers Strensiq (asfotase alfa) for perinatal/infantile- and juvenile-onset hypophosphatasia when criteria are met. To qualify, you need confirmed HPP diagnosis (low ALP + ALPL gene mutation OR elevated substrates), pediatric-onset symptoms, and specialist involvement. Start today: Contact your endocrinologist/

Myths vs. Facts: Getting Rylaze Covered by Cigna in Illinois (2025 Appeals Guide)

Answer Box: Getting Rylaze Covered by Cigna in Illinois Eligibility: Rylaze requires Cigna prior authorization with documented hypersensitivity to E. coli-derived asparaginase for ALL/LBL patients ≥1 month old. Fastest path: Submit complete PA form with hypersensitivity documentation via CoverMyMeds or fax (855) 840-1678. First step today: Download the current

Myths vs. Facts: Getting Arcalyst (rilonacept) Covered by Cigna in Michigan (2025 Appeal Guide)

Quick Answer: Arcalyst (rilonacept) Coverage by Cigna in Michigan Arcalyst requires prior authorization from Cigna for CAPS, DIRA, or recurrent pericarditis. Coverage depends on specialist prescription, documented prior therapy failures (colchicine, NSAIDs, steroids), and medical necessity documentation. If denied, Michigan residents have 180 days for internal appeals and 127 days

Getting Symdeko/Symkevi (Tezacaftor/Ivacaftor) Covered by Cigna in Pennsylvania: Complete Prior Authorization and Appeals Guide

Answer Box: Quick Path to Coverage Symdeko/Symkevi (tezacaftor/ivacaftor) requires prior authorization from Cigna in Pennsylvania. Submit genetic testing showing F508del mutation, CF diagnosis, and specialist prescription via Cigna's provider portal. If denied, use internal appeals within 180 days, then Pennsylvania's Independent External Review (50%

Myths vs. Facts: Getting Rebif (Interferon Beta-1a) Covered by Cigna in New York

Answer Box: Getting Rebif (Interferon Beta-1a) Covered by Cigna in New York Rebif is likely non-formulary on Cigna plans, requiring prior authorization with documented MS diagnosis, MRI activity, and neurologist consultation. Most denials stem from incomplete documentation rather than true medical necessity issues. In New York, you have strong appeal

How to Get Tavalisse (Fostamatinib) Covered by Cigna in New York: Complete Prior Authorization and Appeals Guide

Quick Answer: Getting Tavalisse Covered by Cigna in New York Tavalisse (fostamatinib) requires prior authorization from Cigna for adults with chronic ITP. You'll need a hematologist's prescription, platelet count <30,000/μL (or <50,000/μL with bleeding), and it's dispensed through

How to Get Rezlidhia (Olutasidenib) Covered by Cigna in Illinois: Complete Guide to Prior Authorization and Appeals

Answer Box: Getting Rezlidhia (Olutasidenib) Covered by Cigna in Illinois Rezlidhia (olutasidenib) requires prior authorization from Cigna for adults (≥18) with relapsed/refractory AML confirmed by FDA-approved IDH1 mutation testing. Key requirements: documented IDH1 mutation (R132H, R132C subtypes), monitoring plan for differentiation syndrome and liver function, and oncologist prescriber. Start

How to Get Elelyso (Taliglucerase Alfa) Covered by Cigna in New Jersey: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Elelyso (Taliglucerase Alfa) Covered by Cigna in New Jersey Elelyso (taliglucerase alfa) requires prior authorization from Cigna and is typically covered as a Tier 5 specialty drug for confirmed Type 1 Gaucher disease. Submit the Cerezyme/Elelyso/VPRIV Prior Authorization Form via CoverMyMeds with complete diagnostic documentation.

How to Get Arikayce (Amikacin Liposome Inhalation) Covered by Cigna in Illinois: Complete Prior Authorization and Appeal Guide

Answer Box: Fast Track to Arikayce Coverage Cigna requires prior authorization for Arikayce (amikacin liposome inhalation) through Accredo specialty pharmacy. To get approved in Illinois: (1) Your pulmonologist or infectious disease specialist submits PA documentation showing ≥6 months of failed MAC therapy with positive cultures, (2) Request goes through Express